Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Journal of Academic Ophthalmology (2017)
|
June 30, 2023
Myers-Briggs Type Indicator Personality Types of Ophthalmology Residents
Mohamad Haidar, Faisal Ridha, John Ling, et al.
Journal of Pharmaceutical Sciences
|
September 2, 2005
Disposition and biotransformation of the acetylenic retinoid tazarotene in humans
Mayssa Attar, Dale Yu, Jinsong Ni, et al.
Analytical Biochemistry
|
August 23, 2019
The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation
Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, et al.
Clinical and Translational Science
|
June 27, 2020
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects
Rita Humeniuk, Anita Mathias, Huyen Cao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 10, 2018
Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers
Erik Mogalian, Luisa M Stamm, Anu Osinusi, et al.
Journal of Clinical Pharmacology
|
February 8, 2018
The Drug-Drug Interaction Profile of Presatovir
Yan Xin, Winnie Weng, Bernard P Murray, et al.
Antimicrobial Agents and Chemotherapy
|
March 8, 2024
Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment
Vamshi Jogiraju, Elijah Weber, Jason Hindman, et al.
Pharmacology Research & Perspectives
|
October 4, 2017
Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide
Joseph M Custodio, Susan K Chuck, Hoa Chu, et al.
Journal of Clinical Pharmacology
|
April 18, 2018
Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection
Polina German, Yan Xin, Jason W Chien, et al.
Lancet (London, England)
|
March 14, 2025
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
Vamshi Jogiraju, Pallavi Pawar, Jenna Yager, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Journal of Academic Ophthalmology (2017)
|
June 30, 2023
Myers-Briggs Type Indicator Personality Types of Ophthalmology Residents
Mohamad Haidar, Faisal Ridha, John Ling, et al.
Journal of Pharmaceutical Sciences
|
September 2, 2005
Disposition and biotransformation of the acetylenic retinoid tazarotene in humans
Mayssa Attar, Dale Yu, Jinsong Ni, et al.
Analytical Biochemistry
|
August 23, 2019
The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation
Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, et al.
Clinical and Translational Science
|
June 27, 2020
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects
Rita Humeniuk, Anita Mathias, Huyen Cao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 10, 2018
Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers
Erik Mogalian, Luisa M Stamm, Anu Osinusi, et al.
Journal of Clinical Pharmacology
|
February 8, 2018
The Drug-Drug Interaction Profile of Presatovir
Yan Xin, Winnie Weng, Bernard P Murray, et al.
Antimicrobial Agents and Chemotherapy
|
March 8, 2024
Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment
Vamshi Jogiraju, Elijah Weber, Jason Hindman, et al.
Pharmacology Research & Perspectives
|
October 4, 2017
Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide
Joseph M Custodio, Susan K Chuck, Hoa Chu, et al.
Journal of Clinical Pharmacology
|
April 18, 2018
Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection
Polina German, Yan Xin, Jason W Chien, et al.
Lancet (London, England)
|
March 14, 2025
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
Vamshi Jogiraju, Pallavi Pawar, Jenna Yager, et al.
Page
of 6